Evidence map›Paper›PMID 25329892›Full record

ArticlePloS one2014

A cellular automaton model for tumor dormancy: emergence of a proliferative switch.

Duyu Chen, Yang Jiao, Salvatore Torquato

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Duyu ChenDepartment of Chemistry, Princeton University, Princeton, New Jersey, United States of America; Physical Science in Oncology Center, Princeton University, Princeton, New Jersey, United States of America.
Yang JiaoPhysical Science in Oncology Center, Princeton University, Princeton, New Jersey, United States of America; Materials Science and Engineering, Arizona State University, Tempe, Arizona, United States of America.
Salvatore TorquatoDepartment of Chemistry, Princeton University, Princeton, New Jersey, United States of America; Physical Science in Oncology Center, Princeton University, Princeton, New Jersey, United States of America; Department of Physics, Princeton University, Princeton, New Jersey, United States of America; Program in Applied and Computational Mathematics, Princeton University, Princeton, New Jersey, United States of America; Princeton Institute for the Science and Technology of Materials, Princeton University, Princeton, New Jersey, United States of America.
Princeton University · USArizona State University · US

Funding

TRANS_NETWORK PROJECTSU54CA143803 · NCI · PRINCETON UNIVERSITY · PI TLSTY, THEA D · 2009 to 2013
$14.2M
NCI NIH HHS U54 CA143803NCI NIH HHS U54CA143803
6 · The paper itself

Abstract

Malignant cancers that lead to fatal outcomes for patients may remain dormant for very long periods of time. Although individual mechanisms such as cellular dormancy, angiogenic dormancy and immunosurveillance have been proposed, a comprehensive understanding of cancer dormancy and the "switch" from a dormant to a proliferative state still needs to be strengthened from both a basic and clinical point of view. Computational modeling enables one to explore a variety of scenarios for possible but realistic microscopic dormancy mechanisms and their predicted outcomes. The aim of this paper is to devise such a predictive computational model of dormancy with an emergent "switch" behavior. Specifically, we generalize a previous cellular automaton (CA) model for proliferative growth of solid tumor that now incorporates a variety of cell-level tumor-host interactions and different mechanisms for tumor dormancy, for example the effects of the immune system. Our new CA rules induce a natural "competition" between the tumor and tumor suppression factors in the microenvironment. This competition either results in a "stalemate" for a period of time in which the tumor either eventually wins (spontaneously emerges) or is eradicated; or it leads to a situation in which the tumor is eradicated before such a "stalemate" could ever develop. We also predict that if the number of actively dividing cells within the proliferative rim of the tumor reaches a critical, yet low level, the dormant tumor has a high probability to resume rapid growth. Our findings may shed light on the fundamental understanding of cancer dormancy.

Indexed as

Models, BiologicalCell ProliferationCell Transformation, NeoplasticNeoplasmsNeovascularization, PathologicTumor Microenvironment

Identifiers

PMID25329892
PMCPMC4199683
OpenAlexW1973137168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.